Top Story

Vaccine protected Chinese patients against HEV for up to 4.5 years

March 5, 2015

A vaccine licensed in China protected healthy adults against hepatitis E virus infection for up to 4.5 years, according to newly published data. 

“Vaccine development has been facilitated by the observation that all major genotypes of HEV in humans belong to the same serotype,” the researchers wrote. “Two recombinant hepatitis E vaccines developed from HEV genotype 1 by GlaxoSmithKline and Ziamen Innovax Biotech have had short-term efficacy in clinical trials. The latter vaccine, with the commercial name of Hecolin, has been in use in China since 2012. However, the long-term efficacy of this hepatitis E vaccine has not yet been determined.”

Federal partners develop method for foodborne illness attribution

March 5, 2015
A group of government agencies has developed an improved method to analyze data from outbreaks of foodborne illness to determine the foods responsible for four major…

SCOTUS hears arguments over tax credits for subsidies under ACA

March 4, 2015
The U.S. Supreme Court today began hearing oral arguments in King vs. Burwell, a case that will determine whether the Internal Revenue Service may extend tax-credit…
In the Journals

Nebraska Biocontainment Unit outlines protocol for patient discharge after Ebola

March 4, 2015
The Nebraska Biocontainment Unit at the Nebraska Medical Center, which treated several American patients who acquired Ebola virus in West Africa, released its protocol…
FDA News

FDA launches drug shortage app

March 4, 2015
The FDA has introduced its first mobile application aimed at expediting updates to the public about drug shortages, the agency announced in a press release. The…
More News Headlines »
CME
j526

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »
Meeting News Coverage Video
thumbnail for video 4083453350001

Video: Action needed to reduce CVD risks in HIV patients

February 28, 2015
SEATTLE — Steven Grinspoon, MD, of the Massachusetts General Hospital and Harvard Medical School, gives an…
More »
CME
Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

More »
morganatic-roan
morganatic-roan